BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3594937)

  • 1. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
    Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality.
    Howie AJ; Brewer DB
    J Pathol; 1984 Mar; 142(3):205-20. PubMed ID: 6707787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular tip lesion in the 1962-66 Medical Research Council trial of prednisone in the nephrotic syndrome.
    Howie AJ; Kizaki T
    Nephrol Dial Transplant; 1993; 8(10):1059-63. PubMed ID: 8272216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS; Turner DR; Ogg CS; Sharpstone P; Brown CB
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glomerular tip lesion: a distinct entity or not?
    Huppes W; Hené RJ; Kooiker CJ
    J Pathol; 1988 Feb; 154(2):187-90. PubMed ID: 3280767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
    Yakupoğlu U; Baranowska-Daca E; Suki WN; Truong LD
    Transplant Proc; 2004; 36(1):139-43. PubMed ID: 15013326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up.
    Idelson BA; Smithline N; Smith GW; Harrington JT
    Arch Intern Med; 1977 Jul; 137(7):891-6. PubMed ID: 879928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes at the glomerular tip: a feature of membranous nephropathy and other disorders associated with proteinuria.
    Howie AJ
    J Pathol; 1986 Sep; 150(1):13-20. PubMed ID: 3783320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults.
    Mukherjee AP
    Lancet; 1971 Dec; 2(7738):1350-3. PubMed ID: 4108267
    [No Abstract]   [Full Text] [Related]  

  • 14. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.